Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Abera Bioscience Influenza Vaccine
- Development stage
- Preclinical
- Lead developer
- Abera Bioscience
- Modality
- Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Intranasal
01
Overview
Abera Bioscience's influenza vaccine is an intranasal, mucosal vaccine candidate developed using the company's proprietary Outer Membrane Vesicle (OMV) platform. The vaccine is designed to present hemagglutinin (HA) antigens to the immune system, inducing mucosal immunity to protect against both seasonal and pandemic influenza strains. By utilizing the OMV platform, the vaccine aims to provide a rapid and adaptable response to emerging viral threats. The OMV technology acts as both a delivery vehicle and an inherent adjuvant, potentially enhancing the immune response compared to traditional vaccine platforms. It is currently in advanced preclinical development.
- Other names
- OMV-based Influenza Vaccine
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on Abera Bioscience Influenza Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abera Bioscience Influenza Vaccine.